10 June 2022 | News
The sequencing system will allow healthcare to move closer to preventive precision medicine which will benefit everyone
Redcliffe Labs has announced the addition of ‘NovaSeq 6000’ sequencing system to its diagnostic technology portfolio at its Noida National Reference Lab.
Ease of access to NovaSeq 6000 sequencing system will prove to be very useful, as currently there's no mass level testing protocol rolled out by the states for genetic diseases. Following the successful adoption of NovaSeq 6000 technology, high throughput speed and flexibility will be available to conduct research or tests that need the processing of massive amounts of data more efficiently and cost-effectively.
Moreover, the sophisticated sequencing system will allow healthcare to move closer to preventive precision medicine which will benefit everyone.